Functional activity of the muscarinic positive allosteric modulator VU319 during a Phase 1 Single Ascending Dose study
Authors:
- Alexander ConleyACAlexander Conley
- Alexandra KeyAKAlexandra Key
- Jennifer BlackfordJBJennifer Blackford
- Jerri RookJRJerri Rook
- Jeffrey ConnJCJeffrey Conn
- Craig LindsleyCLCraig Lindsley
- Carrie JonesCJCarrie Jones
- Paul NewhousePNPaul Newhouse
- 1 April 2021
- journal article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 29 (4) , S43